ReposiTrak (NYSE:TRAK) Stock Rating Lowered by Wall Street Zen

ReposiTrak (NYSE:TRAK) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.

Separately, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of ReposiTrak in a report on Monday, December 29th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.

ReposiTrak Stock Performance

Shares of NYSE:TRAK opened at $10.81 on Friday. ReposiTrak has a 52-week low of $10.75 and a 52-week high of $23.72. The company has a market capitalization of $197.71 million, a P/E ratio of 30.03 and a beta of 0.41. The company has a 50-day simple moving average of $13.07 and a 200 day simple moving average of $15.36.

ReposiTrak (NYSE:TRAK) last released its quarterly earnings data on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a return on equity of 14.37% and a net margin of 30.52%.The firm had revenue of $5.97 million for the quarter.

Insider Buying and Selling at ReposiTrak

In other ReposiTrak news, CEO Randall K. Fields sold 2,900 shares of the company’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $10.85, for a total value of $31,465.00. Following the transaction, the chief executive officer directly owned 145,000 shares of the company’s stock, valued at $1,573,250. This represents a 1.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Ronald C. Hodge sold 18,906 shares of the stock in a transaction on Tuesday, December 23rd. The stock was sold at an average price of $13.16, for a total value of $248,802.96. Following the transaction, the director owned 561,869 shares in the company, valued at $7,394,196.04. The trade was a 3.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 103,047 shares of company stock valued at $1,368,242 over the last 90 days. 41.00% of the stock is currently owned by corporate insiders.

Institutional Trading of ReposiTrak

Several hedge funds and other institutional investors have recently bought and sold shares of the business. BNP Paribas Financial Markets boosted its holdings in ReposiTrak by 63.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after purchasing an additional 634 shares during the period. Tower Research Capital LLC TRC raised its position in shares of ReposiTrak by 397.3% in the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after buying an additional 2,892 shares in the last quarter. Copeland Capital Management LLC acquired a new stake in shares of ReposiTrak in the third quarter valued at approximately $54,000. R Squared Ltd bought a new stake in shares of ReposiTrak in the second quarter valued at approximately $235,000. Finally, GSA Capital Partners LLP acquired a new stake in ReposiTrak during the third quarter worth approximately $219,000. Institutional investors and hedge funds own 27.35% of the company’s stock.

About ReposiTrak

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.